tiprankstipranks
Palvella Therapeutics initiated with an Overweight at Cantor Fitzgerald
The Fly

Palvella Therapeutics initiated with an Overweight at Cantor Fitzgerald

Cantor Fitzgerald analyst Josh Schimmer initiated coverage of Palvella Therapeutics (PVLA) with an Overweight rating and $30 price target

Don't Miss Our Christmas Offers:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App